S. Tomlanovich

发表

Improvement in 3-Month Patient-Reported Gastrointestinal Symptoms After Conversion From Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Renal Transplant Patients

P. Bolin, B. Tanriover, G. Zibari, 2007, Transplantation.

Pharmacokinetics of Orally and Intravenously Administered Cyclosporine in Pre—Kidney Transplant Patients

L. Benet, F. Aweeka, S. Tomlanovich, 1994, Journal of clinical pharmacology.

The Risk Of Transmission Of Hepatitis B From Hbsag(-), Hbcab(+), Hbigm(-) Organ Donors

J. Emond, J. Lake, P. Stock, 1995, Transplantation.

Transplant glomerulopathy as a cause of late graft loss.

T. Meyer, S. Tomlanovich, J. Olson, 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

KDOQI US commentary on the 2009 KDIGO clinical practice guideline for the care of kidney transplant recipients.

S. Kulkarni, R. Bloom, L. Chan, 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil--a prospective randomized study. Steroid Withdrawal Study Group.

D. Stablein, M. Pescovitz, A. Matas, 1999, Transplantation.

Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups.

P. Halloran, S. Tomlanovich, C. Groth, 1997, Transplantation.

Efficacy and Safety of Everolimus Plus Low‐Dose Tacrolimus Versus Mycophenolate Mofetil Plus Standard‐Dose Tacrolimus in De Novo Renal Transplant Recipients: 12‐Month Data

F. Luan, S. Mulgaonkar, B. Kaplan, 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Functional Nature of Glomerular Injury in Progressive Diabetic Glomerulopathy

W. Deen, S. Tomlanovich, B. Myers, 1987, Diabetes.

Protocol core needle biopsy and histologic Chronic Allograft Damage Index (CADI) as surrogate end point for long-term graft survival in multicenter studies.

T. Paavonen, M. Navarro, S. Tomlanovich, 2003, Journal of the American Society of Nephrology : JASN.

Limitations of creatinine in quantifying the severity of cyclosporine-induced chronic nephropathy.

S. Tomlanovich, B. Myers, M. Perlroth, 1986, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Role of cardiac atria in the human renal response to changing plasma volume.

F. Murad, H. Sandler, S. Tomlanovich, 1988, The American journal of physiology.

The long-term course of cyclosporine-associated chronic nephropathy.

D. J. Whitney, S. Tomlanovich, B. Myers, 1988, Kidney international.

HISTOPATHOLOGICAL CONCORDANCE OF PAIRED RENAL ALLOGRAFT BIOPSY CORES: EFFECT ON THE DIAGNOSIS AND MANAGEMENT OF ACUTE REJECTION

J. Sorof, S. Tomlanovich, F. Vincenti, 1995, Transplantation.

Ciprofloxacin Prophylaxis in Kidney Transplant Recipients Reduces BK Virus Infection at 3 Months But Not at 1 Year

S. Tomlanovich, F. Vincenti, D. Wojciechowski, 2012, Transplantation.

EVOLVING STRATEGIES FOR IMMUNOSUPPRESSION IN RENAL TRANSPLANTATION: A REVIEW OF RECENT CLINICAL TRIALS*

S. Tomlanovich, T. Pearson, L. Gallon, 2007 .

RS‐61443 (Mycophenolate Mofetil) A Multicenter Study for Refractory Kidney Transplant Rejection

G. Klintmalm, J. Roberts, H. Sollinger, 1992, Annals of surgery.

Mycophenolate mofetil for the treatment of a first acute renal allograft rejection

M. Pescovitz, D. Conti, P. Keown, 1998 .

Rescue therapy with mycophenolate mofetil

M. Pescovitz, D. Conti, E. Woodle, 1996 .

CYTOKINE AND T CELL RECEPTOR GENE EXPRESSION AT THE SITE OF ALLOGRAFT REJECTION1

J. Rabkin, J. Roberts, S. Tomlanovich, 1992, Transplantation.

Sirolimus Prolongs Recovery from Delayed Graft Function After Cadaveric Renal Transplantation

P. Bacchetti, R. McTaggart, S. Feng, 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Early Graft Function After Living Donor Kidney Transplantation Predicts Rejection But Not Outcomes

S. Feng, C. Freise, S. Tomlanovich, 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

EXERCISE INCREASES SELF-REPORTED PHYSICAL FUNCTIONING IN KIDNEY TRANSPLANT RECIPIENTS 1183

P. Painter, S. Tomlanovich, S. Dibble, 1997 .

Cyclosporine-induced chronic nephropathy in human recipients of cardiac allografts.

S. Tomlanovich, B. Myers, M. Moran, 1985, Transplantation proceedings.

Transjugular intrahepatic portosystemic shunts for refractory ascites: Assessment of clinical and hormonal response and renal function

J. Lake, V. Feldstein, S. Tomlanovich, 1995, Hepatology.

Sirolimus: defining nephrotoxicity in the renal transplant recipient.

S. Tomlanovich, F. Vincenti, 2007, Clinical journal of the American Society of Nephrology : CJASN.

Eculizumab for the treatment of de novo thrombotic microangiopathy post simultaneous pancreas-kidney transplantation--a case report.

S. Tomlanovich, L. Baxter‐Lowe, J. Olson, 2011, Transplantation proceedings.

The effects of ketoconazole on the intestinal metabolism and bioavailability of cyclosporine

L. Benet, M. Hebert, S. Tomlanovich, 1995, Clinical pharmacology and therapeutics.

Effect of Food on the Pharmacokinetics of Cyclosporine in Healthy Subjects Following Oral and Intravenous Administration

L. Benet, R. Manfro, S. Tomlanovich, 1990, Journal of clinical pharmacology.

The Role of Donor‐Specific HLA Alloantibodies in Liver Transplantation

G. Klintmalm, A. Kirk, A. Zachary, 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Clinical management of immunosuppressive therapy for cyclosporine-treated recipients of cadaver kidney transplants at one to six months.

S. Tomlanovich, O. Salvatierra, F. Vincenti, 1986, Transplantation proceedings.

Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study1

J. Palefsky, N. Terrault, R. Hirose, 2003, Transplantation.

Long-term outcome in kidney transplant patients with hepatitis C (HCV) infection.

P. Stock, S. Tomlanovich, F. Vincenti, 1995, Clinical transplantation.

Combined Doppler and morphologic sonographic evaluation of renal transplant rejection.

R. Goldstein, R. Filly, S. Tomlanovich, 1990, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

Pharmacokinetics of Mycophenolate Mofetil and Intravenous Ganciclovir Alone and in Combination in Renal Transplant Recipients

F. Aweeka, S. Tomlanovich, S Tomlanovich, 1997, Pharmacotherapy.

Critical care of the end‐stage liver disease patient awaiting liver transplantation

Linda L. Liu, J. Emond, J. Findlay, 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Long-term renal function and cardiovascular disease risk in obese kidney donors.

H. Assadi, A. Posselt, J. Roberts, 2009, Clinical journal of the American Society of Nephrology : CJASN.

Impact of sirolimus on early graft function after deceased-donor kidney transplantation.

R. McTaggart, S. Feng, S. Tomlanovich, 2005, Transplantation.

Immunopharmacodynamic Studies of Cyclosporine in Patients Awaiting Renal Transplantation

L. Benet, F. Aweeka, S. Tomlanovich, 1995, Journal of clinical pharmacology.

Cyclosporin A and prednisolone: an additive inhibitory effect of cell proliferation and interleukin-2 production.

L. Benet, R. Manfro, S. Tomlanovich, 1989, Transplantation proceedings.

Observations relating to the incidence of the acquired immune deficiency syndrome and other possibly associated conditions in a large population of renal transplant recipients.

H. Perkins, S. Tomlanovich, O. Salvatierra, 1987, Transplantation proceedings.

Mycophenolate mofetil in cadaveric renal transplantation

M. M. Rees, G. Danovitch, M. Pescovitz, 1999 .

The role of tacrolimus in adult kidney transplantation: a review.

J. Pirsch, S. Tomlanovich, J. Neylan, 1998, Clinical transplantation.

Determination of soluble IL-2 receptors in kidney graft recipients--a 6-month follow-up.

L. Benet, R. Manfro, S. Tomlanovich, 1990, Transplantation proceedings.

Comparison of Outcomes after Delayed Graft Function: Sirolimus-Based Versus Other Calcineurin-Inhibitor Sparing Induction Immunosuppression Regimens

R. McTaggart, S. Feng, J. Roberts, 2004, Transplantation.

Equivalent Pharmacokinetics of Mycophenolate Mofetil in African‐American and Caucasian Male and Female Stable Renal Allograft Recipients

M. Pescovitz, S. Tomlanovich, G. Bumgardner, 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Intravenous mycophenolate mofetil: safety, tolerability, and pharmacokinetics

M. Pescovitz, D. Conti, B. Kiberd, 2000 .

Intravenous mycophenolate mofetil: safety, tolerability, and pharmacokinetics.

M. Pescovitz, D. Conti, B. Kiberd, 1999, Clinical transplantation.

Recurrent focal glomerulosclerosis: natural history and response to therapy.

S. Tomlanovich, F. Vincenti, M. Artero, 1992, The American journal of medicine.

Is cyclosporine effective in preventing recurrence of immune-mediated glomerular disease after renal transplantation?

S. Tomlanovich, O. Salvatierra, F. Vincenti, 1988, Transplantation proceedings.

Management of end-stage renal disease: transplantation or dialysis?

P. Bretan, S. Tomlanovich, V. Mathur, 1994 .

A prospective, randomized, multicenter study evaluating early corticosteroid withdrawal with Thymoglobulin® in living‐donor kidney transplantation

S. Mulgaonkar, S. Tomlanovich, E. Woodle, 2010, Clinical transplantation.

Determination of blood flow to the transplanted kidney. A novel application of phase-contrast, cine magnetic resonance imaging.

N Pelc, C. McDonnell, N. Pelc, 1994, Transplantation.

Acute renal allograft dysfunction secondary to suprarenal arterial stenosis: a case series and review of the literature.

S. Tomlanovich, R. Kerlan, W. Amend, 1998, Clinical transplantation.

Successful Long‐Term Outcomes Using Pediatric En Bloc Kidneys for Transplantation

R. Hirose, P. Stock, P. Bretan, 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Immunologic and patient selection strategies for successful utilization of less than 15 kg pediatric donor kidneys--long term experiences with 40 transplants.

P. Bretan, S. Tomlanovich, F. Vincenti, 1997, Transplantation.

Renal transplantation in adults with autosomal recessive inheritance of hemolytic uremic syndrome.

S. Tomlanovich, Zulkharnain, B. Kaplan, 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Cyclosporine-induced hemolytic uremic syndrome in a heart transplant recipient.

T. DeMarco, K. Chatterjee, S. Tomlanovich, 1993, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Increased Rejection in Living Unrelated versus Living Related Kidney Transplants does not Affect Short-Term Function and Survival

S. Feng, C. Freise, S. Tomlanovich, 2004, Transplantation.

Cardiorespiratory fitness in pancreas-kidney transplant recipients.

P. Painter, P. Stock, S. Tomlanovich, 1998, Transplantation proceedings.

THE BENEFICIAL EFFECT OF PRETRANSPLANT BLOOD TRANSFUSIONS IN CYCLOSPORINE‐TREATED CADAVER RENAL ALLOGRAFT RECIPIENTS

S. Tomlanovich, F. Vincenti, M. Garovoy, 1987, Transplantation.

Conversion of stable renal allograft recipients to a bioequivalent cyclosporine formulation

R. Merion, T. Pruett, S. Tomlanovich, 2002, Transplantation.

Improved results with combined donor-specific transfusion (DST) and sequential therapy protocol.

J. Rabkin, S. Tomlanovich, O. Salvatierra, 1991, Transplantation proceedings.

Donor-specific blood transfusions versus cyclosporine--the DST story.

S. Tomlanovich, O. Salvatierra, F. Vincenti, 1987, Transplantation proceedings.

Pentoxifylline reduces the first-dose reactions following OKT3.

S. Tomlanovich, F. Vincenti, J. Birnbaum, 1993, Transplantation proceedings.

A prospective, randomized, multicenter study evaluating early corticosteroid withdrawal with Thymoglobulin® in living‐donor kidney transplantation

S. Mulgaonkar, S. Tomlanovich, E. Woodle, 2010, Clinical transplantation.

Living Donor Kidney Transplant Recipients and Clinical Trials: Participation Profiles and Impact on Post‐Transplant Care

S. Feng, S. Tomlanovich, F. Vincenti, 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

P. Painter, K. Topp, P. Stock, 2003, Kidney international.

Efficacy and Safety of Everolimus With Low-Dose Tacrolimus in De Novo Renal Transplant Recipients: 12-Month Randomized Study.: Abstract# 713

F. Luan, S. Mulgaonkar, B. Kaplan, 2014 .